Multiple Choice
Recombinant human parathyroid hormone (PTH) causes bone density to increase by its ability to maintain calcium and phosphorus levels as new bone is formed.In which population is this agent not approved for treatment?
A) Postmenopausal women with severe bone loss
B) Men with osteoporosis who have a high risk of fractures
C) Persons who have not improved on bisphosphonate therapy
D) Perimenopausal women with a family history of osteoporosis
Correct Answer:
Verified
Correct Answer:
Verified
Q1: When a patient has a calcium deficiency,a
Q2: What is the current recommendation of the
Q4: Which food is not considered to be
Q5: Which medical conditions are associated with an
Q6: What unique property does calcitonin possess compared
Q7: What is the best description of premenstrual
Q8: Which option is not a secondary goal
Q9: Women between the ages of 15 and
Q10: What is the mechanism of action of
Q11: For which patient population must a clinician